A Pharmacokinetic Study of Capecitabine in Patients Undergoing Peri-Operative Chemotherapy and a Total Gastrectomy for Adenocarcinoma of the Stomach.
Phase of Trial: Phase IV
Latest Information Update: 23 Jul 2015
At a glance
- Drugs Capecitabine (Primary)
- Indications Gastric cancer
- Focus Pharmacokinetics
- 20 Jul 2015 Status changed from completed to discontinued, as reported by ClinicalTrials.gov.
- 31 Aug 2012 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials.
- 23 Jun 2011 Planned end date changed from 31 Aug 2012 to 1 Nov 2013 as reported by ClinicalTrials.gov.